China Pharma (NYSE:CPHI) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of China Pharma (NYSE:CPHI) in a research report report published on Wednesday morning. The brokerage issued a hold rating on the stock.

China Pharma Trading Down 19.3 %

Shares of China Pharma stock opened at $0.21 on Wednesday. The business has a 50 day simple moving average of $0.21 and a two-hundred day simple moving average of $0.21. China Pharma has a 12 month low of $0.13 and a 12 month high of $0.44. The company has a debt-to-equity ratio of 0.22, a current ratio of 0.79 and a quick ratio of 0.26.

China Pharma Company Profile

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.